Primary open-angle glaucoma: Diagnostic approaches and management

Journal of the National Medical Association

Volumn 101, Issue 1, 2009, Pages 46-50

  Hazin, Ribhi ^a,b   Hendrick, Andrew M ^c   Kahook, Malik Y ^c  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b HARVARD UNIVERSITY   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ADRENALIN; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; APRACLONIDINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; BIMATOPROST; BRIMONIDINE; CARBONATE DEHYDRATASE INHIBITOR; CARTEOLOL; CORTICOSTEROID; DICLOFENAMIDE; DORZOLAMIDE; EYE DROPS; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LATANOPROST; LEVOBUNOLOL; METHAZOLAMIDE; METIPRANOLOL; MIOTIC AGENT; PROSTAGLANDIN DERIVATIVE; TIMOLOL; TRAVOPROST; UNOPROSTONE ISOPROPYL ESTER;

AFRICAN AMERICAN; ALLERGIC REACTION; AMNESIA; AQUEOUS HUMOR FLOW; BAD TASTE IN MOUTH; BLINDNESS; BLURRED VISION; BRADYCARDIA; BRONCHOSPASM; CARDIOVASCULAR DISEASE; CELL DAMAGE; CELL STRUCTURE; CORNEA THICKNESS; DARKENING OF THE IRIS AND LID PIGMENT; DEPRESSION; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DIZZINESS; DRAINAGE IMPLANT; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG SENSITIVITY; EARLY DIAGNOSIS; ERECTILE DYSFUNCTION; ETHNICITY; EYE EXAMINATION; EYE INFLAMMATION; EYE LASH GROWTH; EYE SURGERY; FAMILY HISTORY; FATIGUE; FOLLOW UP; GLAUCOMA; GONIOSCOPY; GROUPS BY AGE; HUMAN; HYPERTENSION; HYPOTENSION; HYPOTHYROIDISM; IMPLANT; INTRAOCULAR PRESSURE; MYOPIA; NEPHROLITHIASIS; NERVE CELL; NERVE FIBER; OPEN ANGLE GLAUCOMA; OPHTHALMOSCOPE; OPHTHALMOSCOPY; OPTIC NERVE INJURY; OPTIC NERVE LESION; OPTIC NERVE TUMOR; PATHOPHYSIOLOGY; PATIENT CARE; PERIMETRY; POLYURIA; PREVALENCE; PREVENTION AND CONTROL; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RASH; RETINAL SWELLING; REVIEW; RISK FACTOR; RISK REDUCTION; SCREENING; SIDE EFFECT; TACHYPHYLAXIS; TONOMETRY; TRABECULOPLASTY; VASCULARIZATION; VISUAL FIELD; VISUAL IMPAIRMENT; XEROSTOMIA;

EID: 61449140114     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-9684(15)30811-7     Document Type: Article

References (45)

1. Distelhorst JS, Hughes GM. Open-angle glaucoma. Am Fam Physician. 2003;67:1937-1944.
2. Weston BC, Aliabadi Z, White GL. Glaucoma-review for the vigilant clinician. Clinician Reviews. 2000:10:59-74.
3. Fleming C, Whitlock EP, Beil T, et al. Screening for primary open-angle glaucoma in the primary care setting: an update for the US preventive services task force. Ann Fam Med. 2005:3:167-170.
4. Kroese M, Burton H. Primary open angle glaucoma. The need for a consensus case definition. J Epidemiol Community Health. 2003:57:752-754.
5. Dueker DK, Singh K, Lin SC, et al. Corneal thickness measurement in the management of primary open-angle glaucoma: a report by the American Academy of Ophthalmology. Ophthalmology. 2007; 114:1779-1787.
6. Suzuki Y, Iwase A, Araie M, et al. Risk factors for open-angle glaucoma in a Japanese population: the Tajimi Study. Ophthalmology. 2006:113:1613-1617.
7. Kymes SM, Kass MA, Anderson DR, et al. Management of ocular hypertension: a cost-effectiveness approach from the Ocular Hypertension Treatment Study. Am J Ophthalmol. 2006:141:997-1008.
8. Nduaguba C, Lee RK. Glaucoma screening: current trends, economic issues, technology, and challenges. Curr Opin Ophthalmol. 2006:17:142-152.
9. Primary Open-Angle Glaucoma; Limited Revision (Preferred Practice Pattern], San Francisco, CA: American Academy of Ophthalmology; 2003.
10. Severn P, Fraser S, Finch T, et al. Which quality of life score is best for glaucoma patients and why? [published online ahead of print], BMC Ophthalmol. 2008:8:2.
11. Gupta N, Yücel YH. Glaucoma as a neurodegenerative disease. Curr Opin Ophthalmol. 2007;18(2):110-114.
12. Flammer J, Mozaffarieh M. What is the present pathogenetic concept of glaucomatous optic neuropathy? Surv Ophthalmol. 2007;52:S162-S173.
13. Meredith SP, Swift L, Eke T, et al. The acute morphologic changes that occur at the optic nerve head induced by medical reduction of intraocular pressure. J Glaucoma. 2007; 16:556-561.
14. Grieshaber MC, Flammer J. Blood flow in glaucoma. Curr Opin Ophthalmol. 2005:16:79-83.
15. Arnalich-Montiel F, Muñoz-Negrete FJ, Rebolleda G, et al. Cup-to- disc ratio: agreement between slit-lamp indirect ophthalmoscopic estimation and stratus optical coherence tomography measurement. Eye. 2007:21:1041-1049.
16. Wordinger RJ, Fleenor DL, Hellberg PE, et al. Effects of TGF-beta2, BMP-4, and gremlin in the trabecular meshwork: implications for glaucoma. Invest Ophthalmol Vis Sci. 2007:48:1191-1200.
17. Harris A, Rechtman E, Siesky B, et al. The role of optic nerve blood flow in the pathogenesis of glaucoma. Ophthalmol Clin North Am. 2005:18:345-353.
18. Morgan JE. Optic nerve head structure in glaucoma: astrocytes as mediators of axonal damage. Eye. 2000:14:437-444.
19. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol. 1996:80:389-393.
20. Friedman DS, Wolfs RC, O'Colmain BJ, et al. Prevalence of open- angle glaucoma among adults in the United States. Arch Ophthalmol. 2004:122:532-538.
21. Wilson MR, Kosoko O, Cowan CL Jr, et al. Progression of visual field loss in untreated glaucoma patients and glaucoma suspects in St Lucia, West Indies. Am J Ophthalmol. 2002:134:399-405.
22. Doshi V, Ying-Lai M, Azen SP, et al. Sociodemographic, Family History, and Lifestyle Risk Factors for Open-angle Glaucoma and Ocular Hypertension The Los Angeles Latino Eye Study [published online ahead of print]. Ophthalmology. 2007.
23. Kosoko-Lasaki O, Gong G, Haynatzki G, et al. Race, ethnicity and prevalence of primary open-angle glaucoma. J Natl Med Assoc. 2006; 98:1626-1629.
24. Schmier JK, Halpern MT, Jones ML. The economic implications of glaucoma: a literature review. Pharmacoeconomics. 2007; 25:287-308.
25. Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet. 2004;363:1711-1720.
26. Green CM, Kearns LS, Wu J, et al. How significant is a family history of glaucoma? Experience from the Glaucoma Inheritance Study in Tasmania. Clin Experiment Ophthalmol. 2007:35:793-799.
27. 27.Leske MC, Connell AM, Schachat AP, et al. The Barbados Eye Study. Prevalence of open angle glaucoma. Arch Ophthalmol. 1994; 112:821 -829.
28. Congdon N, O'Colmain B, Klaver CC, et al. Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004; 122:477-485.
29. Peeters A, Schouten JS, Webers CA, et al. Cost-effectiveness of early detection and treatment of ocular hypertension and primary open-angle glaucoma by the ophthalmologist [published online ahead of print]. Eye. 2006.
30. Konstas AG, Irkec MT, Teus MA, et al. Mean intraocular pressure and progression based on corneal thickness in patients with ocular hypertension [published online ahead of print]. Eye. 2007.
31. Girkin CA, McGwin G Jr, McNeal SF, et al. Hypothyroidism and the development of open-angle glaucoma in a male population. Ophthalmology. 2004; 111:1649-1652.
32. Soares AS, Artes PH, Andreou P, et al. Factors associated with optic disc hemorrhages in glaucoma. Ophthalmology. 2004; 111:1653-1657.
33. Sharkawi E, Franks W. Glaucoma and mortality. Ophthalmology. 2006:113:1069-1076.
34. Song J, Deng PF, Stinnett SS, et al. Effects of cholesterol-lowering statins on the aqueous humor outflow pathway. Invest Ophthalmol Vis Sci. 2005:46:2424-2432.
35. Racette L, Wilson MR, Zangwill LM, et al. Primary open-angle glaucoma in blacks: a review. Surv Ophthalmol. 2003;48:295-313.
36. National Eye Institute, Prevent Blindness America. Vision Problems in the US March 20, 2002. http://www.nei.nih.gov/eyedata/pdf/VPUS.pdf. Accessed May 10,2007.
37. Vass C, Hirn C, Sycha T, et al. Medical interventions for primary open angle glaucoma and ocular hypertension. Cochrane Database Syst Rev. 2007;4:CD003167.
38. Crowston JG, Weinreb RN. Glaucoma medication and aqueous humor dynamics. Curr Opin Ophthalmol. 2005:16:94-100.
39. Mozaffarieh M, Flammer J. Is there more to glaucoma treatment than lowering IOP? Surv Ophthalmol. 2007;52:S174-S179.
40. Whitson JT. Glaucoma: a review of adjunctive therapy and new management strategies. Expert Opin Pharmacother. 2007;8:3237-3249.
41. Barkana Y, Belkin M. Selective laser trabeculoplasty. Surv Ophthalmol. 2007;52:634-654.
42. Hong S, Kim CY, Seong GJ. Long-term intraocular pressure fluctuation and visual field progression in glaucoma patients with low intraocular pressure after post-trabeculectomy phacoemulsification. J Ocul Pharmacol Ther. 2007;23:571-576.
43. Rolim de Moura C, Paranhos A Jr, Wormald R. Laser trabeculoplasty for open angle glaucoma. Cochrane Database Syst Rev. 2007;CD003919.
44. Goulet RJ 3rd, Phan AD, Cantor LB, et al. Efficacy of the Ahmed S2 Glaucoma Valve Compared with the Baerveldf 250-mm(2) Glaucoma Implant [published online ahead of print]. Ophthalmology. 2007.
45. Joshi AB, Parrish RK, Feuer WF. 2002 Survey of the American Glaucoma Society. Practice preferences for glaucoma surgery and antifibrotic use. J Glaucoma. 2005; 14:172-174